Interactive seminar on Garvan institu... - Advanced Prostate...

Advanced Prostate Cancer

22,888 members28,493 posts

Interactive seminar on Garvan institute's work to improve the treatment of advanced cancers, including myeloma, breast and prostate cancer

Seasid profile image
4 Replies

Garvan Institute of Medical Research

Free Public Seminar - Giving cancer no place to hide

SPEAKER/S

Professor Peter Croucher and Associate Professor Christine Chaffer

DATE

10:30am 21 Jun 2024— 11:30am 21 Jun 2024

(AEST)

Join us for an interactive seminar on Garvan’s work to improve the treatment of advanced-stage cancers, including myeloma, breast and prostate cancer.

The majority of cancer deaths arise from advanced-stage disease that has spread around the body and become resistant to treatment. Garvan researchers are tackling these challenges head-on and working towards a future where all cancers can be effectively treated, controlled and prevented.

At this seminar, Professor Peter Croucher will outline Garvan’s world-leading discoveries in cancer dormancy – where cancer cells spread to organs such as bone, resist treatment and hide from the immune system – and how this research will lead to new treatments for advanced breast cancer, advanced prostate cancer and multiple myeloma.

Associate Professor Christine Chaffer will present how patient tissue models and the latest sequencing technologies can be used to study cancer cell plasticity, the ability of cancer cells to switch between different states that help them better spread around the body, to resist therapies and to recur following treatment. She will provide an update on a current clinical trial testing a potential new therapy for triple-negative breast cancer, one of the most aggressive forms of the disease.

Panel

Professor Peter Croucher

Professor Peter Croucher heads Garvan’s Bone Biology Lab, with a longstanding fascination for cancer-associated bone disease. He has a particular interest in the molecular mechanisms of bone disease, how cancer spreads to bone, and what controls dormancy and reactivation of cancer cells within bone. He is motivated by the clinical impacts that his research has already had, and by the potential for widespread future impacts on bone disease, cancer relapse and metastasis.

Associate Professor Christine Chaffer

Associate Professor Christine Chaffer’s passion and career focus is understanding the mechanisms driving cancer development and metastasis, that can lead to translational benefits for patient outcomes. Her team focuses on breast cancer biology, tumour-initiating cells, and mammary gland biology.

By understanding the genetic keys that keep cancer cells dormant, we can not only prevent their awakening but eradicate them entirely. This is the Holy Grail of cancer research.

PROFESSOR PETER CROUCHER

All seminars take place in the auditorium at Garvan Institute of Medical Research

This is a link for registration to the free seminar. Garvan institute.

garvan.org.au/news-resource...

Written by
Seasid profile image
Seasid
To view profiles and participate in discussions please or .
Read more about...
4 Replies
dhccpa profile image
dhccpa

Thank you. Where is Garvan?

Nugger profile image
Nugger in reply todhccpa

384 Victoria StreetDarlinghurst NSW 2010

Australia

Sydney

Seasid profile image
Seasid in reply todhccpa

If you click on the link you could register online to be remotely present via teleconference software.

Magnus1964 profile image
Magnus1964

Thanks for sharing

Not what you're looking for?

You may also like...

ADT Paradox

A treatment paradox has recently come to light in prostate cancer: Blocking testosterone production...

New to the group and new to Advanced Prostate Cancer

Hello everyone, I just found out in late February that I had advanced prostate cancer so I'm still...

Galeterone for the treatment of advanced prostate cancer: the evidence to date

New paper below. Note that the link is to the full text & some will want to read that. Resistance...
pjoshea13 profile image

Recent diagnosis of advanced prostate cancer. Where to begin?

My 68 year old father was just diagnosed with advanced prostate cancer. He has bone mets on almost...
Drew_Fe profile image